Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 38556263)

  • 21. Toxic Effects of Indoxyl Sulfate on Osteoclastogenesis and Osteoblastogenesis.
    Shyu JF; Liu WC; Zheng CM; Fang TC; Hou YC; Chang CT; Liao TY; Chen YC; Lu KC
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indoxyl sulfate is a nephro-vascular toxin.
    Niwa T
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S2-6. PubMed ID: 20797565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indoxyl sulfate: a candidate target for the prevention and treatment of cardiovascular disease in chronic kidney disease.
    Barisione C; Ghigliotti G; Canepa M; Balbi M; Brunelli C; Ameri P
    Curr Drug Targets; 2015; 16(4):366-72. PubMed ID: 25537654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of uremic toxin indoxyl sulfate in the progression of cardiovascular disease.
    Gao H; Liu S
    Life Sci; 2017 Sep; 185():23-29. PubMed ID: 28754616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indoxyl Sulfate, a Uremic Endotheliotoxin.
    Lano G; Burtey S; Sallée M
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32260489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbial-Derived Tryptophan Catabolites, Kidney Disease and Gut Inflammation.
    Madella AM; Van Bergenhenegouwen J; Garssen J; Masereeuw R; Overbeek SA
    Toxins (Basel); 2022 Sep; 14(9):. PubMed ID: 36136583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indoxyl sulfate, a valuable biomarker in chronic kidney disease and dialysis.
    Tan X; Cao X; Zou J; Shen B; Zhang X; Liu Z; Lv W; Teng J; Ding X
    Hemodial Int; 2017 Apr; 21(2):161-167. PubMed ID: 27616754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
    Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting protein-bound uremic toxins in chronic kidney disease.
    Niwa T
    Expert Opin Ther Targets; 2013 Nov; 17(11):1287-301. PubMed ID: 23941498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease.
    Sallée M; Dou L; Cerini C; Poitevin S; Brunet P; Burtey S
    Toxins (Basel); 2014 Mar; 6(3):934-49. PubMed ID: 24599232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indoxyl sulfate contributes to colorectal cancer cell proliferation and increased EGFR expression by activating AhR and Akt.
    Ichisaka Y; Yano S; Nishimura K; Niwa T; Shimizu H
    Biomed Res; 2024; 45(2):57-66. PubMed ID: 38556263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
    Brito JS; Borges NA; Esgalhado M; Magliano DC; Soulage CO; Mafra D
    Nephron; 2017; 137(1):1-7. PubMed ID: 28490014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aryl hydrocarbon receptor (AhR) and its endogenous agonist - indoxyl sulfate in chronic kidney disease.
    Kamiński T; Michałowska M; Pawlak D
    Postepy Hig Med Dosw (Online); 2017 Jul; 71(0):624-632. PubMed ID: 28791957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indoxyl sulfate induces nephrovascular senescence.
    Niwa T; Shimizu H
    J Ren Nutr; 2012 Jan; 22(1):102-6. PubMed ID: 22200425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uremic toxicity of indoxyl sulfate.
    Niwa T
    Nagoya J Med Sci; 2010 Feb; 72(1-2):1-11. PubMed ID: 20229698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.